Cargando…

MIS-C Triggered by Omicron Variant of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Balasubramanian, S., Dhanalakshmi, K., Lakshan Raj, S., Chandy, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Clinical Case Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160844/ https://www.ncbi.nlm.nih.gov/pubmed/35567320 http://dx.doi.org/10.1007/s13312-022-2526-1

Ejemplares similares

Differentiating Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Mimics–A Single-Center Experience From a Tropical Setting
por: Balasubramanian, S., et al.
Publicado: (2023)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

What Is New With Omicron Variant of SARS-CoV-2 in Children?
por: Bittmann, Stefan, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variants in Bangladesh: Pandemic to endemic
por: Jubair, Mohammad, et al.
Publicado: (2023)

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022)

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
por: McMahan, Katherine, et al.
Publicado: (2022)

Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
por: Mattiuzzi, C., et al.
Publicado: (2022)

Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital
por: Madhusudan, Manoj, et al.
Publicado: (2021)

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
por: Ou, Jianxia, et al.
Publicado: (2022)

Cognitive dysfunction of patients infected with SARS-CoV-2 omicron variant in Shanghai, China
por: Yuan, Ping, et al.
Publicado: (2023)

Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C
por: Tang, Juanjie, et al.
Publicado: (2022)

Appearance of a sore throat caused by the SARS‐CoV‐2 Omicron variant
por: Yamashita, Takeshi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
por: Kim, Eun-Young, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain
por: Chin, Alex Wing Hong, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
por: Tang, Juanjie, et al.
Publicado: (2022)

Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA
por: Seid, Arlene G., et al.
Publicado: (2022)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters
por: Zhang, Ya-Nan, et al.
Publicado: (2022)

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed
por: Huang, Jing, et al.
Publicado: (2022)

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
por: Tai, Wanbo, et al.
Publicado: (2022)

The importance of an early gastroenteritis diagnosis to discard MIS-C during SARS-CoV-2 pandemic
por: Miaja, María Fernández, et al.
Publicado: (2022)

High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection
por: Zheng, Jing, et al.
Publicado: (2022)

It is not the time to relax yet: masks are still needed for the Omicron variant of SARS-CoV-2
por: Lowe, Scott, et al.
Publicado: (2022)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

International risk of SARS-CoV-2 Omicron variant importations originating in South Africa
por: Bai, Yuan, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Variant in Human Saliva Samples in Cell-Free Form
por: Imai, Kenichi, et al.
Publicado: (2023)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a0tmjs7qqvrjhivg1c1i8r1f5h